🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06707090
Recruiting Phase 3

Tissue Repair Gel in Venous Leg Ulcers (US)

NCT06707090 · tracked via the Priya Life Science USA tracker
Sponsor
TR Therapeutics
Phase
Phase 3
Started
2025-01-28
Last updated
2026-02-12

Condition(s) studied

Venous Leg UlcerVenous UlcerVenous Stasis UlcerVenous StasisWound HealWoundsVenous Insufficiency of LegNon-healing Wound

Investigational drug(s) / intervention(s)

TR987 0.1% gel + Standard of Care →Standard of care

TR987 0.1% gel + Standard of Care: 6mg topical gel for application plus Standard of Care (wound cleansing/dressings and compression bandaging)

Standard of care: Standard of Care (wound cleansing/dressings and compression bandaging)

Study summary

The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Adults 18 years and older * Venous insufficiency has been clinically diagnosed clinically and medically confirmed. * Females who are neither pregnant nor breastfeeding and if of child-bearing potential are on an acceptable method of birth control. * The Venous Ulcer should be between 2 cm2 and 12 cm2 at randomization. * Target ulcer age must be ≥ 4 weeks at Screening. * Participants must have adequate arterial flow as confirmed by ABI/TBI, TB, SPP, TCPo2, or Duplex Doppler. * Body mass index (BMI) ≤ 50 kg/m2. * HbA1C ≤12%. Exclusion Criteria: * Target ulcer has been treated with prohibited medications or therapies. * History of radiation at the target ulcer site. * Target ulcer decreases in area by 30% or more during screening period. * History of osteomyelitis at the target ulcer within 6 months of screening. * Participants considered nutritionally deficient.

Primary outcome measure(s)

Trial sites (33)

FacilityCityRegionStatus
Clincial Research Site 21 Tucson Arizona Active Not Recruiting
Clincial Research Site 43C Castro Valley California Recruiting
Clincial Research Site 14 Fresno California Recruiting
Clincial Research Site 11 Los Angeles California Recruiting
Clincial Research Site 43A San Francisco California Recruiting
Clincial Research Site 43B San Francisco California Recruiting
Clincial Research Site 54 Vista California Recruiting
Clincial Research Site 47 Deerfield Beach Florida Active Not Recruiting
Clincial Research Site 38 Hollywood Florida Not Yet Recruiting
Clincial Research Site 40 Jacksonville Florida Recruiting
Clincial Research Site 19 Miami Florida Recruiting
Clincial Research Site 26 Miami Florida Recruiting
Clincial Research Site 13 Pembrook Pines Florida Recruiting
Clincial Research Site 51 Tamarac Florida Withdrawn
Clincial Research Site 22 Chicago Illinois Not Yet Recruiting
Clincial Research Site 34 Chicago Illinois Recruiting
Clincial Research Site 10 O'Fallon Illinois Recruiting
Clincial Research Site 49 Springfield Illinois Recruiting
Clincial Research Site 04 Bossier City Louisiana Recruiting
Clincial Research Site 01 Lafayette Louisiana Recruiting
Clincial Research Site 07 D'Iberville Mississippi Recruiting
Clincial Research Site 02 McComb Mississippi Recruiting
Clincial Research Site 30 New York New York Recruiting
Clincial Research Site 37 Syosset New York Recruiting
Clincial Research Site 55 Winston-Salem North Carolina Active Not Recruiting
Clincial Research Site 45 Grove City Ohio Withdrawn
Clincial Research Site 23 Mentor Ohio Withdrawn
Clincial Research Site 28 Tulsa Oklahoma Recruiting
Clincial Research Site 36 Philadelphia Pennsylvania Recruiting
Clincial Research Site 24 Fort Worth Texas Recruiting
Clincial Research Site 32 Houston Texas Recruiting
Clincial Research Site 46 San Antonio Texas Not Yet Recruiting
Clincial Research Site 18 Suffolk Virginia Recruiting

More TR Therapeutics trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06707090 on ClinicalTrials.gov ↗ ← All trials in the USA